You are here: Industry Insights > pancreatic

News List

Blood test can detect early stage pancreatic cancer europeanpharmaceuticalreview
April 22, 2019
A blood test has been developed to detect pancreatic cancer at its earliest stages with an accuracy rate of 96 percent…
Some Patients With Imminently Fatal Cancer Undergo Treatment drugs
April 18, 2019
Some patients with imminently fatal de novo metastatic cancer undergo treatment.
US FDA grants Lynparza Orphan Drug Designation for pancreatic cancer biospectrumasia
October 17, 2018
Press Release Lynparza AstraZeneca Merck & Co. FDA Pancreatic Cancer Regulatory Affairs
Ovarian cancer drug shows promise in pancreatic cancer patients with BRCA mutation worldpharmanews
May 23, 2018
A targeted therapy that has shown its power in fighting ovarian cancer in women including those with BRCA1 and BRCA2 mutations may also help patients with aggressive pancreatic cancer who harbor these mutations and have few or no other treatment options.
Unique pancreatic stem cells have potential to regenerate beta cells, respond to glucose worldpharmanews
March 01, 2018
Scientists from the Diabetes Research Institute at the University of Miami Miller School of Medicine have confirmed the existence of progenitor cells within the human pancreas that can be stimulated to develop into glucose-responsive beta cells.
Fast-track pancreatic cancer surgery boosts success, saves money pharmatimes
August 03, 2017
Accelerating access to pancreatic surgery has been shown to boost success rates by more than a fifth with a cost saving to the NHS of around £3,200 per patient.
Partnering cells turn off immune attack on pancreatic tumors biospectrumasia
July 20, 2017
These are the findings of a study in mice led by researchers from NYU Langone Medical Center and its Perlmutter Cancer Center, and published online July 18 in Cell Reports.
Cancer Research UK to support Precision Panc project for pancreatic cancer pharmaceutical-technology
March 27, 2017
Cancer Research UK has announced an investment of £10m to support the Precision Panc project, which aims to develop personalised treatments for pancreatic cancer patients.

Previous page 1 2 Next page